Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep748 | Pituitary and Neuroendocrinology | ECE2022

Clinical, paraclinical and genetic features of diabetes insipidus

Mnif Fatma , Charfi Hana , Abdelhedi Fatma , Bouassida Malek , Elleuch Mouna , Salah Dhoha Ben , Mnif Mouna , Majdoub Nabila Rekik , Charfi Nadia , Akid Faten Haj Kacem , Kammoun Hassen , Abid Mohamed

Introduction: Diabetes insipidus (DI) is a rare pathology. The advent of hypothalamic-pituitary MRI has made it possible to make a positive diagnosis by avoiding the water restriction test (WRT). The etiological diagnosis is still a challenge in view of the diversity of diseases involved, which influences the therapeutic management and prognosis.Work Objectives: The objectives of our work were to describe the clinical, paraclinical and genetic features o...

ea0081ep750 | Pituitary and Neuroendocrinology | ECE2022

Neurosarcoidosis and pituitary metastasis of a small cell carcinoma: an unusual association

Mnif Fatma , Charfi Hana , Elleuch Mouna , Salah Dhoha Ben , Charfi Nadia , Mnif Mouna , Majdoub Nabila Rekik , Akid Faten Haj Kacem , Abid Mohamed

Introduction: Pituitary stalk thickening (PST) is often identified on magnetic resonance imaging (MRI), either incidentally or during diagnostic workup of hypopituitarism. Currently, there is no unified standard for the definition of PST. As a reference, a pituitary stalk with width over 3 mm has been used as the diagnostic criterion for PST in recent years. The disease spectrum of PST is quite diverse and can be grouped into three broad categories: neoplastic, inflammatory an...

ea0081ep824 | Pituitary and Neuroendocrinology | ECE2022

What factors predict a favorable response to hormonal therapy in congenital growth hormone deficiency?

Rekik Majdoub Nabila , ARBI Kawthar El , Zargni Asma , Salah Dhoha Ben , Benothman Wafa , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Mnif Mouna , Akid Faten Haj Kacem , Abid Mohamed

Introduction: Growth hormone (GH) treatment in congenital growth hormone deficiency (CGHD) is indicated to improve the prognosis of the statural prognosis. The aim of this study is to identify the predictive factors of a favorable response to GH therapy.Patients & Methods: This is a retrospective study, conducted over a period of 27 years, including 30 patients with CGHD treated with hormonal therapy.Results: The CGHD was diagn...

ea0081ep1104 | Thyroid | ECE2022

Graves’ disease: Particularities in the pediatric population

Ben Salah Dhoha , ARBI Kawthar El , Zargni Asma , Elleuch Mouna , Chehaider Cyrine , Fatma Mnif , Charfi Nadia , Mnif Mouna , Majdoub Nabila Rekik , Akid Faten Haj Kacem , Abid Mohamed

Introduction: Graves’ disease (GD) is the most common cause of hyperthyroidism in pediatric patients, up to 95% in some studies.Observation: We report the observation of a 6-year-old female who consulted for a behavioral disorder made of agitation and lack of concentration. She had a family history of autoimmune thyroid disease. On examination, an accelerated statural growth rate of +2DS was noted. She had a significant palpebral retraction without ...

ea0081ep1161 | Thyroid | ECE2022

Case report: Amiodarone-induced thyroid dysfunction

Akid Faten Haj Kacem , Trimeche Oumeyma , Missaoui AbdelMouhaymen , Salah Dhoha Ben , Fatma Mnif , Charfi Nadia , Mnif Mouna , Majdoub Nabila Rekik , Elleuch Mouna , Abid Mohamed

Amiodarone is considered by many the most potent antiarrhythmic drug. The other side of the coin is that it’s associated with many side effects including disturbances in the thyroid function, which can be seen in 14 to 18 % of the cases (1). This case is about a 56-year-old male patient with a history of mitral valve disease who was on Amiodarone for 3 years. His personal history was notable with Epilepsy of unknow etiology for which he was on sodium valproate. During fol...

ea0090p694 | Pituitary and Neuroendocrinology | ECE2023

Management challenges of gestational pituitary adenoma

Fatma Mnif , Trimeche Oumeyma , Mouhaymen Missaoui Abdel , Ben Salah Dhoha , Elleuch Mouna , Haj Kacem Akid Faten , Charfi Nadia , Mnif Mouna , Rekik Majdoub Nabila , Abid Mohamed

Pituitary apoplexy is a rare condition and gestational pituitary apoplexy (GPA) is even more exceptional. Clinical presentation of GPA is often non-specific overlapping with other conditions, making its diagnosis challenging. Additionally, therapeutic management is often limited since it depends on both the mother’s and the fetus’s prognosis. Herein we report of a woman who was diagnosed with GPA and we discuss the management of her case. A 34-year-old woman with no ...

ea0090p711 | Pituitary and Neuroendocrinology | ECE2023

Prevalence and associated factors related to combined hypopituitarism in patients with congenital Growth Hormone deficiency

Haj Kacem Akid Faten , Belabed Wafa , Mouhaymen Missaoui Abdel , Safi Wajdi , Ben Salah Dhoha , Mnif Fatma , Mejdoub Nabila , Mnif Mouna , Abid Mohamed

Background and aim: Congenital Growth hormone deficiency (CGHD) may result from genetic or congenital disorders of pituitary development. It could be isolated or combined with other types of hypopituitarism. This study aims to evaluate the prevalence of combined hypopituitarism and its associated factors in patients with CGHD.Patients and Methods: We conducted a retrospective study (1991-2019) at the Endocrinology department of Hedi Chaker University Hos...

ea0090p196 | Reproductive and Developmental Endocrinology | ECE2023

Metabolic syndrome in Turner syndrome

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Mouhaymen Missaoui Abdel , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Turner syndrome (TS) is a feminine chromosomic disease, defined as the partial or total loss of the X chromosome. Classic phenotype includes growth and pubertal retardation as well as a characteristic dysmorphic syndrome. Other accompanying comorbidities are frequently associated with TS such as metabolic diseases: overweight, diabetes, hypertension (HTA) and dyslipidemia. Through this report we aim to determine the frequency of metabolic diseases associated with...

ea0090p197 | Reproductive and Developmental Endocrinology | ECE2023

Polycystic ovary syndrome phenotype and therapeutic outcomes

Elleuch Mouna , Frikha Hamdi , Ben Salah Dhoha , Triki Molka , Ayadi Younes , Mnif Fatma , Mnif Mouna , Rekik Majdoub Nabila , Charfi Nadia , Haj Kacem Akid Faten , Abid Mohamed

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting women of reproductive age. PCOS has two phenotypes, obese and lean, the latter being a much less common presentation of the syndrome.Aim: Compare PCOS outcomes in patients with obese PCOS and patients with lean PCOS.Methods: A retrospective, single-center, descriptive and comparative study including patients with PCOS followed at the endocrinology d...

ea0090p445 | Reproductive and Developmental Endocrinology | ECE2023

Auto-immune diseases in Turner syndrome

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Khochtali Rihab , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Turner syndrome (TS) is a genetic disease, attributable to the total or partial loss of an X chromosome. The classic phenotype encompasses short stature, hypergonadotropic hypogonadism and dysmorphic features. It’s also associated with other conditions such as autoimmune (AI) diseases. Aim: Herein we aim to determine the frequency of AI diseases in TS and to identify the genetic variants of TS mostly associated with this latter conditi...